In this role, Dr Superko will provide medical leadership for Celera’s cardiovascular products and services through oversight of education programs and participation in relevant medical associations, professional societies and groups responsible for the establishment of guidelines regarding the adoption of new diagnostics. Dr Superko will report to Kathy Ordonez, Celera’s CEO.
Dr Superko is a Fellow of the American College of Cardiology, the American Heart Association, the American College of Sports Medicine and the American Association of Cardiovascular and Pulmonary Rehabilitation. He is currently the executive director at the Center for Genomics and Human Health at St Joseph’s Translational Research Institute in Atlanta, Georgia.
Dr Superko currently sits on committees at the American Heart Association, the Trans Catheter Therapeutics Scientific Advisory Committee, American Heart Association Atherosclerotic Peripheral Vascular Disease Committee, and the Atlanta American Heart Association Board.
Ms Ordonez said: “We are delighted that Robert has joined Celera to provide medical oversight to our cardiovascular programs, and to serve as the lead interface with the cardiovascular medical community.
“We believe Robert’s experience in helping facilitate clinical utilization of novel diagnostics will be important to our success as we seek to have tests, such Berkeley HeartLab’s KIF6 laboratory developed test, adopted broadly by the medical community.”